Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
Lancet Oncol
; 16(15): 1537-1546, 2015 Nov.
Article
in En
| MEDLINE
| ID: mdl-26474521
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rectal Neoplasms
/
Adenocarcinoma
/
Neoadjuvant Therapy
/
Chemoradiotherapy
/
Organ Sparing Treatments
Type of study:
Clinical_trials
/
Guideline
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Lancet Oncol
Journal subject:
NEOPLASIAS
Year:
2015
Type:
Article